fluconazolo ratiopharm
teva italia s.r.l. - fluconazolo - fluconazolo
ciqorin
teva italia s.r.l. - ciclosporina - ciclosporina
kisplyx
eisai gmbh - lenvatinib mesilato - carcinoma, cellule renali - agenti antineoplastici - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
fluconazol-mepha teva 50 mg capsule rigide
mepha pharma ag - fluconazolum - capsule rigide - fluconazolum 50 mg, lactosum monohydricum 47 mg, maydis amylum, silica colloidalis anhydrica, natrii laurilsulfas, magnesii stearas, kapselhülle: e 171, e 133, gelatina, pro capsula corresp. natrium 0.009 mg. - antifungini - synthetika
fluconazol-mepha teva 100 mg capsule rigide
mepha pharma ag - fluconazolum - capsule rigide - fluconazolum 100 mg, lactosum monohydricum 94 mg, maydis amylum, silica colloidalis anhydrica, natrii laurilsulfas, magnesii stearas, kapselhülle: e 171, e 133, gelatina, pro capsula corresp. natrium 0.015 mg. - antifungini - synthetika
fluconazol-mepha teva 150 mg capsule rigide
mepha pharma ag - fluconazolum - capsule rigide - fluconazolum 150 mg, lactosum monohydricum 141 mg, maydis amylum, silica colloidalis anhydrica, natrii laurilsulfas, magnesii stearas, kapselhülle: e 171, e 133, gelatina, pro capsula corresp. natrium 0.027 mg. - antifungini - synthetika
fluconazol-mepha teva 200 mg capsule rigide
mepha pharma ag - fluconazolum - capsule rigide - fluconazolum 200 mg, lactosum monohydricum 188 mg, maydis amylum, silica colloidalis anhydrica, natrii laurilsulfas, magnesii stearas, kapselhülle: e 171, e 133, e 122 0.090 mg, gelatina, pro capsula corresp. natrium 0.036 mg. - antifungini - synthetika
promus element plus monorail btk everolimus-eluting stent system
boston scientific corporation - stent vascolari periferici a cessione di farmaco (des)
promus element plus over-the-wire btk everolimus-eluting stent system
boston scientific corporation - stent vascolari periferici a cessione di farmaco (des)
xience v everolimus eluting coronary stent system
abbott vascular, cardiac therapies - stent coronarici a cessione di farmaco (des)